Continuous lenalidomide improves overall survival in multiple myeloma

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2011年 / 72卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：309 / 309
页数：1
相关论文
共 50 条
  • [41] Thrombotic events in patients with multiple myeloma and their impact on overall survival
    Chen, Haimin
    Zhang, Ying
    Wang, Zhenzhen
    Wu, Lixia
    Fei, Xichang
    Wei, Wei
    Peng, Rong
    Chen, Xiaoling
    Shi, Haotian
    Zhou, Nian
    Yu, Wenjun
    Zhao, Wenhao
    Zhou, Fan
    HEMATOLOGY, 2025, 30 (01)
  • [42] Overall survival as a primary end point in multiple myeloma trials
    Edward R. Scheffer Cliff
    Ghulam Rehman Mohyuddin
    Nature Reviews Clinical Oncology, 2022, 19 : 565 - 566
  • [43] CAN OVERALL SURVIVAL BE IMPROVED IN ELDERLY MULTIPLE MYELOMA PATIENTS?
    Heeg, B. M.
    Liwing, J.
    Karstorp, S.
    Postma, M.
    Silvennoinen, R.
    Putkonen, M.
    Anttila, P.
    Remes, K.
    Abildgaard, N.
    Waage, A.
    Nahi, H.
    HAEMATOLOGICA, 2015, 100 : 517 - 517
  • [44] Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma
    Chanan-Khan, Asher A.
    Lonial, Sagar
    Weber, Donna
    Borrello, Ivan
    Foa, Robin
    Hellmann, Andrzej
    Dimopoulos, Meletios
    Swern, Arlene S.
    Knight, Robert
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (02) : 254 - 262
  • [45] Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma
    Asher A. Chanan-Khan
    Sagar Lonial
    Donna Weber
    Ivan Borrello
    Robin Foà
    Andrzej Hellmann
    Meletios Dimopoulos
    Arlene S. Swern
    Robert Knight
    International Journal of Hematology, 2012, 96 : 254 - 262
  • [46] Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial
    Dimopoulos, Meletios A.
    Oriol, Albert
    Nahi, Hareth
    San-Miguel, Jesus
    Bahlis, Nizar J.
    Usmani, Saad Z.
    Rabin, Neil
    Orlowski, Robert Z.
    Suzuki, Kenshi
    Plesner, Torben
    Yoon, Sung-Soo
    Ben Yehuda, Dina
    Richardson, Paul G.
    Goldschmidt, Hartmut
    Reece, Donna
    Ahmadi, Tahamtan
    Qin, Xiang
    Mayo, Wendy Garvin
    Gai, Xue
    Carey, Jodi
    Carson, Robin
    Moreau, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08) : 1590 - +
  • [47] Survival of Patients with Multiple Myeloma That Is Refractory to Both Bortezomib and Lenalidomide: A Retrospective Study
    Miyazaki, Kanji
    Suzuki, Kenshi
    BLOOD, 2018, 132
  • [48] Thalidomide As Maintenance Therapy in Multiple Myeloma (MM) Improves Progression Free Survival (PFS) and Overall Survival (OS): A Meta-Analysis
    Nooka, Ajay K.
    Behera, Madhusmita
    Boise, Lawrence H.
    Watson, Melanie
    Kaufman, Jonathan L.
    Lonial, Sagar
    BLOOD, 2011, 118 (21) : 807 - 808
  • [49] Maintenance Lenalidomide After Transplantation in Multiple Myeloma Prolongs Survival-In Most
    Mikhael, Joseph R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (29) : 3269 - +
  • [50] Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
    Macauda, Angelica
    Clay-Gilmour, Alyssa
    Hielscher, Thomas
    Hildebrandt, Michelle A. T.
    Kruszewski, Marcin
    Orlowski, Robert Z.
    Kumar, Shaji K.
    Ziv, Elad
    Orciuolo, Enrico
    Brown, Elizabeth E.
    Forsti, Asta
    Waller, Rosalie G.
    Machiela, Mitchell J.
    Chanock, Stephen J.
    Camp, Nicola J.
    Rymko, Marcin
    Rany, Malgorzata
    Cozen, Wendy
    Varkonyi, Judit
    Piredda, Chiara
    Pelosini, Matteo
    Belachew, Alem A.
    Subocz, Edyta
    Hemminki, Kari
    Rybicka-Ramos, Malwina
    Giles, Graham G.
    Milne, Roger L.
    Hofmann, Jonathan N.
    Zaucha, Jan Maciej
    Vangsted, Annette Juul
    Goldschmidt, Hartmut
    Rajkumar, S. Vincent
    Tomczak, Waldemar
    Sainz, Juan
    Butrym, Aleksandra
    Watek, Marzena
    Iskierka-Jazdzewska, Elzbieta
    Buda, Gabriele
    Robinson, Dennis P.
    Jurczyszyn, Artur
    Dudzinski, Marek
    Martinez-Lopez, Joaquin
    Sinnwell, Jason P.
    Slager, Susan L.
    Jamroziak, Krzysztof
    Reis, Rui Manuel Vieira
    Weinhold, Niels
    Bhatti, Parveen
    Carvajal-Carmona, Luis G.
    Zawirska, Daria
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (09) : 1863 - 1866
12345